Navigation Links
Company Appoints New SVP, Marketing for PBM Business

WOONSOCKET, R.I., Nov. 4 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today announced the appointment of Len Greer to the position of SVP, Marketing for its pharmacy benefit management business. Greer assumes responsibility for the company's PBM marketing from Jack Bruner, who is transitioning to the new role of EVP, Strategic Development.

(Logo: )

Greer brings twenty years of experience in marketing, strategy and product development to CVS Caremark. He joins the company from ActiveHealth where he was the EVP, Marketing responsible for developing and implementing marketing strategies to drive brand awareness in the health plan and plan sponsor marketplace. Prior to his tenure with ActiveHealth he spent six years at Medco Health in various senior marketing roles. Before joining Medco, Greer was a management consultant at McKinsey & Company, where he assisted clients on issues of marketing, strategy, product development and operations.

"Len's analytical background, knowledge of the industry and strong marketing skills make him uniquely qualified to help deliver our messages effectively in the marketplace," commented Tom Ryan, President, Chairman and CEO.

Len holds a bachelor's degree from the Illinois Institute of Technology and a master's degree in business administration from the University of Michigan.

About CVS Caremark

CVS Caremark is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 7,000 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, General information about CVS Caremark is available through the Investor Relations section of the Company's Web site, at, as well as through the press room section of the Company's Web site, at

    Media Contact:
    Eileen Howard Dunn                  Nancy Christal
    CVS Caremark                        CVS Caremark
    Senior Vice President               Senior Vice President
    Corporate Communications            Investor Relations
    (401) 770-4561                      (914) 722-4704


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
2. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
3. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
4. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
5. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
6. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
7. Female Health Company Receives Brazilian Order: Four Million FC Female Condoms
8. The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
9. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
10. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
11. Maine Natural Health Company Conducts Dental Clinical Trial
Post Your Comments:
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center ... Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This annual ... the world’s leading providers of cereal and other breakfast foods. Its residents often refer ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
Breaking Medicine News(10 mins):